Invest in companies creating customized health solutions in the next medical revolution.
Motif Human Evolution Total Return Index
Base Date: August 16, 2013, return data prior to January 9, 2019 for the Index is based on hypothetical performance data derived using the Index rules as of January 9, 2019, but applied retroactively using historical stock position levels. You should not take the hypothetical return data of the Index as an indication of the future performance of the Index. Past performance is no guarantee of future results and may be lower or higher than current performance. Investing in financial products inolves risks to be considered prior to making any investment decision. An investment in a financial product linked to the Index should only be made after a review of companies included in the Index and such financial product linked to the Index, including a review of the risks associated with such companies or product. Past performance is no guarantee of future results.
An investment in the companies identified by the Human Evolution theme or in financial products linked to such theme should only be made after a review of such companies or products, including a review of the risks associated with such companies or products.
The Motif Human Evolution Index is designed to deliver exposure to companies that may benefit from the development of new knowledge, medicines and technologies for the medical treatment of the human condition, from birth to end-of-life care.
The Human Evolution Theme is separated into multiple innovations. The innovations are:
Precision Medicine: the innovation represents companies that may benefit from the development of precise medical treatments. For the purposes of the Index, “Precision Medicine” refers to medical treatments or techniques that are either physically precise, targeting a specific group or type of cells, or tailored to a group of patients.
Genomics: the innovation represents companies that may benefit from the development of
genomics. For the purposes of the Index, “Genomics” refers to the study of genomes, including genome sequencing and bioinformatics, and its application to healthcare as genomic medicine and pharmacogenomics, including gene therapy, gene editing and the use of biomarkers.
Life Extension: the innovation represents companies that may benefit from the long-term demographic shift towards an older population. For the purposes of the Index, “Life Extension” refers to medical products and services geared towards managing the health of an aging population.
Robotic Surgery: the innovation represents companies that may benefit from the development of robotic surgery. For the purposes of the Index, “Robotic Surgery” refers to technology that enables minimally invasive surgery, as well as the use of miniaturized surgical instruments and robotic systems to assist in surgical procedures.
Digital Health: the innovation represents companies that may benefit from the development of digital health tools. For the purposes of the Index, “Digital Health” refers to the use of electronic data and soware tools of analysis to assist in healthcare treatment and the development of drugs.
All Motif portfolios and investing models are developed through Motif Capital Management. Motif Thematic Portfolios, Motif Impact Portfolios are made available through Motif. Goldman Sachs Motif Structured Notes, Separately Managed Accounts are based on indices and portfolios built and managed by Motif Capital Management.
Motif Capital may only transact business in those jurisdictions where it is registered. Any communication with prospective clients residing in locations where Motif is not registered or licensed shall be limited so as not to trigger registration or licensing requirements. The purpose of the website is to provide information, products, and services and should not be considered investment advice, recommendation, or a solicitation to buy or sell any particular securities. Past performance does not guarantee future performance. The strategies and/or investments referenced are provided for informational purposes only and may not be suitable for all investors as the appropriateness of particular investment or strategy will depend on an investor’s individual circumstances and objectives. Please refer to additional important information by clicking on the Form ADV.
Motif Capital Management, Inc., is an SEC-registered investment adviser and a separate, wholly-owned subsidiary of Motif Investing, Inc., a registered broker-dealer and member SIPC.